Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Daniel E Ball"'
Publikováno v:
Patient Preference and Adherence, Vol 2010, Iss default, Pp 263-271 (2010)
Douglas L Noordsy1, Glenn A Phillips2, Daniel E Ball2, Walter T Linde-Zwirble31Department of Psychiatry, Dartmouth Medical School, Lebanon, NH, USA; 2Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA; 3ZD Associates, Perkasie, PA,
Externí odkaz:
https://doaj.org/article/859e0bf4ee034ce695d400f455033e03
Autor:
Tim MacLeod, Magda Ruth Baksh, Otelo Corrêa dos Santos Filho, Ishtar Govia, Luis Miguel Gutierrez Robledo, Hisatomo Kowa, Craig W. Ritchie, Deanna R Willis, Justine Coppinger, Daniel E Ball, James F Murray, Emily A. Largent
Publikováno v:
Alzheimer's & Dementia. 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7304058403c90df4891d43e130260c
https://doi.org/10.1002/alz.063746
https://doi.org/10.1002/alz.063746
Autor:
Daniel E. Ball, Soeren Mattke, Lori Frank, James F. Murray, Ryoji Noritake, Timothy MacLeod, Samantha Benham‐Hermetz, Alissa Kurzman, Phyllis Ferrell
Publikováno v:
Alzheimer'sdementia : the journal of the Alzheimer's AssociationREFERENCES.
Confronting Alzheimer's disease (AD) involves patients, healthcare professionals, supportive services, caregivers, and government agencies interacting along a continuum from initial awareness to diagnosis, treatment, support, and care. This complex s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f892bbfc2ae1b6183d175f925ba539
https://pubmed.ncbi.nlm.nih.gov/36478657
https://pubmed.ncbi.nlm.nih.gov/36478657
Autor:
Noam Y. Kirson, Miriam L. Zichlin, Daniel E. Ball, Urvi Desai, J. Scott Andrews, Brandy R. Matthews
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction This study estimated the minimal clinically important difference (MCID) for Mini Mental State Examination, Clinical Dementia Rating Scale sum of boxes, and Functional Activities Questionnaire across the Alzheimer's disease (AD) spectrum.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e647d54fd8e4b8ef0a944760c4be4a59
http://europepmc.org/articles/PMC6690415
http://europepmc.org/articles/PMC6690415
Autor:
Sarah B. King, Noam Y. Kirson, Kristin Kahle-Wrobleski, Sophie A Schonfeld, Urvi Desai, J. Scott Andrews, Howard G. Birnbaum, Daniel E. Ball
Publikováno v:
Journal of Alzheimer's Disease
Background: Effectiveness of Alzheimer’s disease (AD) treatments may depend critically on the timeliness of intervention. Objective: To compare characteristics and outcomes of patients diagnosed with probable AD (prAD) based on time elapsed from fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::894e9c62902f785968ee52d52b41384f
https://doi.org/10.3233/jad-170078
https://doi.org/10.3233/jad-170078
Publikováno v:
The Journals of Gerontology: Series A. 72:811-817
Background Spouses of Alzheimer's disease patients (AD spouses) may experience substantial health effects associated with their partner's chronic cognitive and behavioral dysfunction. Studies examining associations between the medical experiences of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::147f8e96b6a040af8482315067a3e24c
https://doi.org/10.1093/gerona/glx029
https://doi.org/10.1093/gerona/glx029
Autor:
Adam S. Fleisher, Virginia S. Haynes, Vishal Saundankar, Michael M. Witte, Radhika Nair, Derek van Amerongen, Mir Siadaty, Daniel E. Ball, Leslie Ann Hazel Fernandez, AnnCatherine M. Downing, Nick C. Patel
Publikováno v:
BMC Geriatrics
BMC Geriatrics, Vol 18, Iss 1, Pp 1-12 (2018)
BMC Geriatrics, Vol 18, Iss 1, Pp 1-12 (2018)
Background The objective of this study was to examine patient characteristics and health care resource utilization (HCRU) in the 36 months prior to a confirmatory diagnosis of Alzheimer’s disease (AD) compared to a matched cohort without dementia d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7430cb7272b28061a3f1632e280385e
http://europepmc.org/articles/PMC6192320
http://europepmc.org/articles/PMC6192320
Autor:
Serge Gauthier, Yaakov Stern, Dorene M. Rentz, Jeffrey Scott Andrews, Daniel E. Ball, Wenyu Ye
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::accb1707ed1a5ba463dc208f2a3551d3
https://doi.org/10.1016/j.jalz.2018.06.317
https://doi.org/10.1016/j.jalz.2018.06.317
Autor:
Noam Y. Kirson, Brandy R. Matthews, Miriam L. Zichlin, Daniel E. Ball, Jeffrey Scott Andrews, Urvi Desai
Publikováno v:
Alzheimer's & Dementia. 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6e00f07e7946140ae0b3a4e24cf9989
https://doi.org/10.1016/j.jalz.2018.06.1035
https://doi.org/10.1016/j.jalz.2018.06.1035
Autor:
Anita Chawla, Dave Nellesen, Daniel E. Ball, Adrian Towse, Daniel S. Mytelka, Louis P. Garrison, Anupama Kalsekar, Stephan D. McBride, Benjamin R. Elkins
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose To evaluate the advantages and disadvantages of pre-approval requirements for safety data to detect cardiovascular (CV) risk contained in the December 2008 U.S. Food and Drug Administration (FDA) guidance for developing type 2 diabetes drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d06878cd18611b4ba11f9fc263c0fb4
http://europepmc.org/articles/PMC4285165
http://europepmc.org/articles/PMC4285165